Compare HESM & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HESM | MMSI |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.0B |
| IPO Year | 2019 | 1996 |
| Metric | HESM | MMSI |
|---|---|---|
| Price | $39.26 | $69.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $41.57 | ★ $100.38 |
| AVG Volume (30 Days) | ★ 1.1M | 730.8K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | ★ 7.77% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | ★ $1,621,300,000.00 | $1,515,906,000.00 |
| Revenue This Year | $1.59 | $8.78 |
| Revenue Next Year | $3.10 | $5.76 |
| P/E Ratio | ★ $13.07 | $31.63 |
| Revenue Growth | 8.41 | ★ 11.75 |
| 52 Week Low | $31.63 | $66.34 |
| 52 Week High | $44.14 | $99.26 |
| Indicator | HESM | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 43.39 |
| Support Level | $38.56 | $66.88 |
| Resistance Level | $40.62 | $84.91 |
| Average True Range (ATR) | 0.87 | 1.86 |
| MACD | -0.16 | 0.45 |
| Stochastic Oscillator | 59.31 | 54.50 |
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.